AI At The Frontier: Empowering Early Career Professionals In Drug Discovery
Elrig
APRIL 29, 2024
Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups. There, I supported AI-enabled DD efforts in their small molecule portfolio.
59 
Let's personalize your content